D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 83 Citations 26,573 305 World Ranking 8270 National Ranking 4506

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Endocrinology

Paul N. Hopkins mostly deals with Internal medicine, Endocrinology, Cardiology, Cholesterol and Familial hypercholesterolemia. His Endocrinology study frequently draws connections to adjacent fields such as Allele. His Cardiology research includes themes of Family history and Diastole.

Paul N. Hopkins focuses mostly in the field of Cholesterol, narrowing it down to topics relating to Hyperlipidemia and, in certain cases, Triglyceride. His Familial hypercholesterolemia research incorporates elements of Genetics, Pediatrics, Apolipoprotein B and Lipoprotein. His research in Pediatrics intersects with topics in Hyperlipoproteinemia Type II and Genetic testing.

His most cited work include:

  • Molecular basis of human hypertension: Role of angiotensinogen (1680 citations)
  • Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia (481 citations)
  • Health Benefits of Gastric Bypass Surgery after 6 Years (477 citations)

What are the main themes of his work throughout his whole career to date?

Paul N. Hopkins mainly focuses on Internal medicine, Endocrinology, Blood pressure, Cardiology and Genetics. Internal medicine is a component of his Cholesterol, Body mass index, Lipoprotein, Renin–angiotensin system and Familial hypercholesterolemia studies. While the research belongs to areas of Body mass index, Paul N. Hopkins spends his time largely on the problem of Obesity, intersecting his research to questions surrounding Diabetes mellitus.

His Familial hypercholesterolemia study combines topics in areas such as LDL receptor, Disease, Pediatrics and Apolipoprotein B. As part of one scientific family, Paul N. Hopkins deals mainly with the area of Endocrinology, narrowing it down to issues related to the Single-nucleotide polymorphism, and often Haplotype. His studies in Cardiology integrate themes in fields like Odds ratio, Left ventricular hypertrophy, Diastole and Risk factor.

He most often published in these fields:

  • Internal medicine (75.41%)
  • Endocrinology (57.03%)
  • Blood pressure (20.00%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (75.41%)
  • Endocrinology (57.03%)
  • Familial hypercholesterolemia (16.22%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Endocrinology, Familial hypercholesterolemia, Coronary artery disease and Alirocumab. Paul N. Hopkins is involved in the study of Internal medicine that focuses on Blood pressure in particular. His work deals with themes such as Genetic testing, Genotype, MEDLINE and Bioinformatics, which intersect with Familial hypercholesterolemia.

The various areas that Paul N. Hopkins examines in his Coronary artery disease study include Myocardial infarction, Revascularization, Pediatrics and Kidney transplantation. He has included themes like Stroke, Transplantation and Survival rate in his Cardiology study. Paul N. Hopkins has researched Diabetes mellitus in several fields, including Sphingolipid and Obesity.

Between 2015 and 2021, his most popular works were:

  • Weight and Metabolic Outcomes 12 Years after Gastric Bypass (364 citations)
  • The Unrecognized Prevalence of Primary Aldosteronism. (56 citations)
  • Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease (34 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

His primary scientific interests are in Internal medicine, Endocrinology, Coronary artery disease, Diabetes mellitus and Inflammation. When carried out as part of a general Endocrinology research project, his work on Insulin resistance, LDL receptor, Apolipoprotein B and Familial hypercholesterolemia is frequently linked to work in Alirocumab, therefore connecting diverse disciplines of study. His Coronary artery disease study is related to the wider topic of Cardiology.

The study incorporates disciplines such as Odds ratio, Placebo, Menopause and Estrogen in addition to Cardiology. His work carried out in the field of Diabetes mellitus brings together such families of science as Framingham Risk Score, Sphingolipid, Heart disease and Cholesterol. His Inflammation study incorporates themes from Atrophy and Skeletal muscle.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Molecular basis of human hypertension: Role of angiotensinogen

Xavier Jeunemaitre;Florent Soubrier;Yuri V. Kotelevtsev;Richard P. Lifton;Richard P. Lifton.
Cell (1992)

2461 Citations

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Anne C. Goldberg;Paul N. Hopkins;Peter P. Toth;Christie M. Ballantyne.
Journal of Clinical Lipidology (2011)

737 Citations

Health Benefits of Gastric Bypass Surgery after 6 Years

Ted D. Adams;Lance E. Davidson;Sheldon E. Litwin;Sheldon E. Litwin;Ronette L. Kolotkin.
JAMA (2012)

697 Citations

Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease

Paul N. Hopkins;Lily L. Wu;Steven C. Hunt;Brent C. James.
Arteriosclerosis, Thrombosis, and Vascular Biology (1996)

602 Citations

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

Roger R. Williams;Roger R. Williams;Roger R. Williams;Steven C. Hunt;Steven C. Hunt;Steven C. Hunt;M.Catherine Schumacher;M.Catherine Schumacher;M.Catherine Schumacher;Robert A. Hegele;Robert A. Hegele;Robert A. Hegele.
American Journal of Cardiology (1993)

579 Citations

Familial and genetic determinants of systemic markers of inflammation : the NHLBI family heart study

James S Pankow;Aaron R Folsom;Mary Cushman;Ingrid B Borecki.
Atherosclerosis (2001)

499 Citations

A survey of 246 suggested coronary risk factors

Paul N Hopkins;Roger R Williams.
Atherosclerosis (1981)

465 Citations

Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects Hypertension Genetic Epidemiology Network (HyperGEN) Study

Vittorio Palmieri;Jonathan N. Bella;Donna K. Arnett;Jennifer E. Liu.
Circulation (2001)

451 Citations

Weight and Metabolic Outcomes 12 Years after Gastric Bypass

Ted D. Adams;Ted D. Adams;Lance E. Davidson;Lance E. Davidson;Sheldon E. Litwin;Jaewhan Kim.
The New England Journal of Medicine (2017)

442 Citations

Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.

Roger R. Williams;Steven C. Hunt;Paul N. Hopkins;Barry M. Stults.
JAMA (1988)

431 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul N. Hopkins

Steven C. Hunt

Steven C. Hunt

Cornell University

Publications: 123

Gerald F. Watts

Gerald F. Watts

University of Western Australia

Publications: 114

Jose M. Ordovas

Jose M. Ordovas

Tufts University

Publications: 103

Donna K. Arnett

Donna K. Arnett

University of South Carolina

Publications: 89

Richard B. Devereux

Richard B. Devereux

Cornell University

Publications: 83

Eric Boerwinkle

Eric Boerwinkle

The University of Texas Health Science Center at Houston

Publications: 75

Gordon H. Williams

Gordon H. Williams

Brigham and Women's Hospital

Publications: 67

Robert A. Hegele

Robert A. Hegele

University of Western Ontario

Publications: 66

Ramachandran S. Vasan

Ramachandran S. Vasan

Boston University

Publications: 56

Daniel Levy

Daniel Levy

National Institutes of Health

Publications: 53

Giovanni de Simone

Giovanni de Simone

University of Naples Federico II

Publications: 52

Steve E. Humphries

Steve E. Humphries

University College London

Publications: 52

Emelia J. Benjamin

Emelia J. Benjamin

Boston University

Publications: 51

Luc Djoussé

Luc Djoussé

Brigham and Women's Hospital

Publications: 50

D. C. Rao

D. C. Rao

Washington University in St. Louis

Publications: 49

Michael A. Province

Michael A. Province

Washington University in St. Louis

Publications: 48

Trending Scientists

Lujo Bauer

Lujo Bauer

Carnegie Mellon University

Manfred Thumm

Manfred Thumm

Karlsruhe Institute of Technology

Andrew J. Flewitt

Andrew J. Flewitt

University of Cambridge

John H. Johnson

John H. Johnson

Michigan Technological University

Giuliano C. Premier

Giuliano C. Premier

University of New South Wales

Weston Thatcher Borden

Weston Thatcher Borden

University of Washington

Jeremy L. Gilbert

Jeremy L. Gilbert

Medical University of South Carolina

Bin Tang

Bin Tang

Taiyuan University of Technology

Stefanie M. Hauck

Stefanie M. Hauck

Sanofi (France)

Paul E. Fraser

Paul E. Fraser

University of Toronto

Matthew D. Hirschey

Matthew D. Hirschey

Duke University

Dierk Scheel

Dierk Scheel

Leibniz Association

Volker Freudenthaler

Volker Freudenthaler

Ludwig-Maximilians-Universität München

Xueguang Zhang

Xueguang Zhang

Soochow University

Kimberly Andrews Espy

Kimberly Andrews Espy

University of Arizona

Jan Delabie

Jan Delabie

University Health Network

Something went wrong. Please try again later.